retatrutide clinical trial dose just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Phase III retatrutide study demonstrates

These therapies have a central role in improving glycemic control and reducing cardiovascular risk

For Heathcare Professionals For use by physicians GLP-1 medications like Ozempic, Wegovy, and similar drugs have changed the way many people manage type 2 diabetes and weight loss

GIP receptor activation complements the effects of GLP-1, further enhancing satiety and helping the body process and store nutrients more efficiently

Chemokines Chemokines provide directional cues for leukocyte trafficking to inflamed sites and participate in T-cell activation, B-cell class-switch recombination, neutrophil degranulation, dendritic-cell maturation and macrophage activation

Further well-designed, multicenter randomized controlled trials employing standardized and sensitive apnea detection methods are essential to definitively evaluate this potential application (45, 78)